Surviving a SARS-CoV-2 infection may be a reason to be more vigilant about general CV prevention measures moving forward.

The experts provide a how-to on dealing with sticky situations, such as no-flow and large thrombus, during PCI for STEMI.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

Whether to use ATP is not clear-cut and the choice should be made through shared decision-making, one expert says.

Cellular immunotherapies for cancer are associated with a low rate of serious adverse cardiac events in patients with ...

A study reinforces the importance of supporting the arm and placing the BP cuff at heart level, as guidelines recommend.

The incidental mammogram finding isn’t a reason to panic, but it might a reason to make sure other risk factors are under ...

Guideline recommendations for acute pulmonary embolism (PE) developed by prominent professional societies give a mixed bag of advice across the US and Europe, according to a paper published online ...

The randomized study lasted just 3 months, but researchers saw “multiple cardiometabolic benefits” beyond weight loss.

Two new analyses from HELIOS-B answer important questions, but some uncertainties remain, says Julie Rosenthal.

In one study, outcomes were similar regardless of baseline LVEF and recent worsening HF emerged as an important indicator.

Indications that the GLP-1 drug has greater benefits in the most frail patients should be viewed cautiously, one expert says.